Future Medicines Institute Application
Lead Participant:
QUEEN'S UNIVERSITY BELFAST
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| QUEEN'S UNIVERSITY BELFAST | £25,921,468 | £ 20,734,582 |
Participant |
||
| PROAXSIS LTD | £1,208,243 | £ 845,649 |
| SONRAI ANALYTICS LTD | £1,013,777 | £ 709,644 |
| FUSION ANTIBODIES PLC | £1,710,064 | £ 1,025,867 |
| ULSTER UNIVERSITY SIPF | £3,985,449 | £ 3,187,961 |
| EXPLORISTICS LTD | £464,276 | £ 232,138 |
| RANDOX LABORATORIES LIMITED | £3,624,200 | £ 1,812,100 |
| ALMAC DISCOVERY LIMITED | £10,770,990 | £ 5,385,495 |
| DIACEUTICS PLC | £995,996 | £ 497,998 |
| ALMAC DIAGNOSTIC SERVICES LIMITED | £599,800 | £ 299,900 |
| HEALTH INNOVATION RESEARCH ALLIANCE | £93,404 | £ 65,373 |
People |
ORCID iD |
| James Mawhinney (Project Manager) |